JP Patent

JP3389493B2 — リン酸結合性ポリマー製剤

Assigned to Chugai Pharmaceutical Co Ltd · Expires 2003-03-24 · 23y expired

What this patent protects

Patent listed against Renvela.

Drugs covered by this patent

Renvela (SEVELAMER CARBONATE) · Sanofi

Patent Metadata

Patent number: JP3389493B2
Jurisdiction: JP
Classification: —
Expires: 2003-03-24
Drug substance claim: No
Drug product claim: No
Assignee: Chugai Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.